Should I buy Houlihan Lokey (HLI) stock or is it too late?

Houlihan Lokey · Financials · price $131

See the full Houlihan Lokey (HLI) profile

⭐ What the most reliable analysts say · those who beat their sector, targets replayed on real prices

⭐ The most reliable of them, either direction: Keefe, Bruyette & Woods — 67% of its targets hit on this sector (279 calls tested). It aims for $153 (+17 %), call made on July 31, 2026, maturing on July 31, 2027 (28 d ago).

The 3 reliable analysts $148+13 %

The 2 other firms $161+23 %

How to read it: the 3 reliable firms are not filtered by optimism — 3 aim above the price, 0 below, hence their $148 median. “The 2 others” are the firms that don't pass our reliability filter on this sector.

Firm-by-firm track record on Houlihan Lokey

Here the hit rate is measured <b>on this stock specifically</b> (matured targets replayed against real prices, minimum 5 calls tested) — the green block above measures reliability <b>across the whole sector</b>, which is the criterion behind JPI selections. “Aims for” = the firm's most recent target on this stock; “—” means it hasn't published one recently.

Firm	% right	Gain vs sector	Calls	Aims for
UBS	75 %	+23.8 %	16	$147 +12%
Morgan Stanley	67 %	-1.1 %	12	$177 +35%
Wells Fargo	25 %	-12.0 %	8	$209 +60%

In short — Should you invest in Houlihan Lokey? Is it too late, still worth it? Analysts are overwhelmingly positive (80% buy, median target $148, i.e. +13%), and the most reliable on HLI targets even higher. We give you both sides, with the numbers — not advice.

✅ Reasons to believe

80% of analysts rate it a buy (Buy consensus, 5 ratings) — a sign of market conviction.
Median price target $148, i.e. +13% from the current price ($131).
The most reliable firm on HLI, UBS (75% hit rate, 16 scored calls), targets $147 (call made on July 30, 2026, maturing on July 30, 2027) (+12%) in its most recent call, and $163 (call made on March 12, 2026, maturing on March 12, 2027) (+25%) in the one coming due soonest.
Pays a dividend (1.8% yield), raised for 10 years — regular income on top of potential upside.

⚠️ Reasons to hesitate

The consensus is not unanimous: of 5 ratings, 1 is neutral.
A 12-month target is not a guaranteed path: the price can fall in the meantime.

The analyst consensus on HLI

Median target $148 (+13%) · 5 ratings · Buy consensus

Strong Buy00%

Buy480%

Hold120%

Sell00%

Strong Sell00%

⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.

Frequently asked questions

Should you invest in Houlihan Lokey now?

We won't decide for you. The facts: 80% of analysts rate it a buy, median target $148 (+13%), and UBS (most reliable on HLI, 75%) targets $147. Weigh that against valuation. This is not personalized advice.

Is it too late to invest in Houlihan Lokey?

Not according to analysts: the median target ($148) is still +13% above the current price ($131) (most reliable on HLI: UBS, 75%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.

Is Houlihan Lokey still worth investing in?

It depends on the gap between the price ($131) and its estimated value: analysts target $148 on median (+13%), with 80% buys (most reliable on HLI: UBS, 75%). Cross-check with their real reliability on HLI and the cautions above. Information, not advice.

What's the main risk in buying HLI?

The consensus is not unanimous: of 5 ratings, 1 is neutral.

→ Go deeper: the full Houlihan Lokey profile (consensus, analyst reliability, price target, performance).